Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion type Assertion NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_head.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion description "[Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_provenance.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion evidence source_evidence_literature NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_provenance.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion SIO_000772 10482985 NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_provenance.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion wasDerivedFrom befree-2016 NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_provenance.
- NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_assertion wasGeneratedBy ECO_0000203 NP262770.RAYKNw9bc32DZttYXvfPsv_sMXWOCbPNXT3qihvmE0A-Q130_provenance.